Article révisé par les pairs
Titre:
  • Keynote comment: reimbursement for molecularly targeted anticancer agents.
Auteur:Tirelli, Umberto; de Castro, Gilberto; Awada, Ahmad
Informations sur la publication:Lancet oncology, 7, 1, page (2-3)
Statut de publication:Publié, 2006-01
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Antineoplastic Agents -- economics
Antineoplastic Agents -- therapeutic use
Cost-Benefit Analysis
Drug Approval
Drug Costs
Economics, Pharmaceutical
Genes, Neoplasm
Humans
Insurance, Health, Reimbursement
Molecular Biology
Neoplasms -- drug therapy
Neoplasms -- genetics
Neoplasms -- physiopathology
Note générale:Letter
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(05)70512-X
info:pii/S1470-2045(05)70512-X
info:scp/29744462010
info:pmid/16389172